Abstract
Ebolaviruses are the causative agent of a severe hemorrhagic fever with high case fatality rates, for which no approved specific therapy is available. As biosafety level 4 (BSL4) agents, work with live ebolaviruses is restricted to maximum containment laboratories. Transcription and replication-competent viruslike particle (trVLP) systems are reverse genetics-based life cycle modeling systems that allow researchers to model virtually the entire ebolavirus life cycle outside of a maximum containment laboratory. These systems can be used to dissect the virus life cycle, and thus increase our understanding of virus biology, as well as for more applied uses such as the screening and development of novel antivirals, and thus represent powerful tools for work on ebolaviruses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Feldmann H, Geisbert TW (2011) Ebola haemorrhagic fever. Lancet 377(9768):849–862. doi:10.1016/S0140-6736(10)60667-8
Mendoza EJ, Qiu X, Kobinger GP (2016) Progression of Ebola therapeutics during the 2014-2015 outbreak. Trends Mol Med 22(2):164–173. doi:10.1016/j.molmed.2015.12.005
Hoenen T, Groseth A, de Kok-Mercado F, Kuhn JH, Wahl-Jensen V (2011) Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses. Antivir Res 91(2):195–208. doi:10.1016/j.antiviral.2011.06.003
Muhlberger E, Weik M, Volchkov VE, Klenk HD, Becker S (1999) Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J Virol 73(3):2333–2342
Watanabe S, Watanabe T, Noda T, Takada A, Feldmann H, Jasenosky LD, Kawaoka Y (2004) Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics. J Virol 78(2):999–1005
Hoenen T, Groseth A, Kolesnikova L, Theriault S, Ebihara H, Hartlieb B, Bamberg S, Feldmann H, Stroher U, Becker S (2006) Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24. J Virol 80(14):7260–7264. doi:10.1128/JVI.00051-06
Watt A, Moukambi F, Banadyga L, Groseth A, Callison J, Herwig A, Ebihara H, Feldmann H, Hoenen T (2014) A novel life cycle Modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity. J Virol 88(18):10511–10524. doi:10.1128/JVI.01272-14
Hoenen T (2017) Minigenome systems for filoviruses. In: Salvato MS (ed) Hemorrhagic fever viruses: methods and protocols. Springer (New York)
Watanabe S, Noda T, Halfmann P, Jasenosky L, Kawaoka Y (2007) Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome. J Infect Dis 196(Suppl 2):S284–S290. doi:10.1086/520582
Hoenen T, Jung S, Herwig A, Groseth A, Becker S (2010) Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription. Virology 403(1):56–66. doi:10.1016/j.virol.2010.04.002
Spiegelberg L, Wahl-Jensen V, Kolesnikova L, Feldmann H, Becker S, Hoenen T (2011) Genus-specific recruitment of filovirus ribonucleoprotein complexes into budding particles. J Gen Virol 92(Pt 12):2900–2905. doi:10.1099/vir.0.036863-0
Hoenen T, Watt A, Mora A, Feldmann H (2014) Modeling the lifecycle of Ebola virus under biosafety level 2 conditions with virus-like particles containing tetracistronic minigenomes. J Vis Exp 91:52381. doi:10.3791/52381
Biedenkopf N, Lier C, Becker S (2016) Dynamic phosphorylation of VP30 is essential for Ebola virus life cycle. J Virol 90(10):4914–4925. doi:10.1128/JVI.03257-15
Hoenen T, Feldmann H (2014) Reverse genetics systems as tools for the development of novel therapies against filoviruses. Expert Rev Anti-Infect Ther 12(10):1253–1263. doi:10.1586/14787210.2014.948848
Wenigenrath J, Kolesnikova L, Hoenen T, Mittler E, Becker S (2010) Establishment and application of an infectious virus-like particle system for Marburg virus. J Gen Virol 91(Pt 5):1325–1334. doi:10.1099/vir.0.018226-0
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Biedenkopf, N., Hoenen, T. (2017). Modeling the Ebolavirus Life Cycle with Transcription and Replication-Competent Viruslike Particle Assays. In: Hoenen, T., Groseth, A. (eds) Ebolaviruses. Methods in Molecular Biology, vol 1628. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7116-9_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7116-9_9
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7115-2
Online ISBN: 978-1-4939-7116-9
eBook Packages: Springer Protocols